Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 15 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
System and method for combined I/Q generation and selective phase interpolation
Pre-primed roofing membrane
Device and process for isolating and cultivating live cells on a filter or extracting their genetic material
Inducement of organogenetic tolerance for pancreatic xenotransplant
Browsing or searching user interfaces and other aspects
Method, apparatus and article for detection of transponder tagged objects, for example during surgery
Energy drink package
  Randomly Featured Patents
Cardio-thoracic compression harness
Vaporizer in a liquid material vaporizing and feeding apparatus
Process and apparatus for reclaiming the economic components of scrap rubber tires
Governing the serving of advertisements based on a cost target
Portable communication device and method of use
Gutter sweeper system
Digital image capture and processing system having a printed circuit (PC) board with a light transmission aperture, wherein an image detection array is mounted on the rear side of said PC boar
Low voltage differential dual receiver
Apparatus for external fixation of a fractured distal radius with angularly adjustable pin clamping means